Published in Blood Weekly, April 12th, 2001
"Augmentation of the level of fetal hemoglobin (HbF) is considered therapeutic for patients with sickle cell disease," D. Lavelle and colleagues with the U.S. Veterans Administration explained in the journal Experimental Hematology.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.